User:FlowTrialFraser
Editor·2,955 edits·since 2025/03
FlowTrialFraser is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on clinical trials and evidence appraisal. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,955Total edits
20Logged here
15Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| LEADER trial | 3 | 31 | 10% |
| Intention-to-treat analysis | 2 | 26 | 8% |
| Thermo Fisher Scientific (China) | 1 | 33 | 3% |
| Shanghai Sigma-Audley New Material Technology | 1 | 37 | 3% |
| Chain of custody | 1 | 39 | 3% |
| Peptide synthesis | 1 | 39 | 3% |
| Preparative HPLC purification | 1 | 33 | 3% |
| Cold-chain freight | 1 | 28 | 4% |
| TRIUMPH trial programme | 1 | 31 | 3% |
| Weight regain after discontinuation | 1 | 33 | 3% |
| Number needed to treat | 1 | 28 | 4% |
| Peptide harm reduction | 1 | 39 | 3% |
| Sarcopenia | 1 | 31 | 3% |
| Injection site rotation | 1 | 26 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.